Navigation Links
Dominion Diagnostics Announces Launch of Comprehensive New Company Website
Date:3/27/2008

NORTH KINGSTOWN, R.I., March 27 /PRNewswire/ -- Dominion Diagnostics, LLC, the premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring, and support services nationwide, today announced the launch of a new, comprehensive website. The new site, http://www.dominiondiagnostics.com, is operational as of March 21, 2008. The launch is part of Dominion's continuing initiative to provide unmatched laboratory and customer services and create a centralized location of organized information and resources for the healthcare community.

"The website offers many of the same great features as our previous website, however it's been designed to be more user-friendly and content rich," Chief Operating Officer Stephen Jordan said. "Our Web Development team successfully captured our intent, in terms of design, valuable content and ease of navigation."

The first phase of Dominion's new website launch provides visitors with 24-hour access to information about the company's history and mission, its comprehensive laboratory and customer services, relevant news and resources, frequently asked questions, and multiple points of contact within the company's diverse professional staff. Additionally, the website provides useful links to other relevant organizations' websites that support the variety of medical specialties Dominion serves.

Dominion's website also grants clients access to Dominion Select(TM) online services via http://www.dominiondiagnostics.com/members. Dominion Select(TM) is a private, password-protected website designed as a repository for convenient, web-based results and resources. Through secure online access, Dominion Select(TM) allows clients to view up-to-the-minute patient laboratory results, review Scientifically Accurate Medication Monitoring (SAMM) (TM) reports, download reports specific to their practice, access important industry news and resources, and contact various support departments through HIPAA-secure feedback options.

Future phases of the website launch, anticipated over the next year, will provide greater access to advanced educational resources, interactive training platforms, and sections focused on SAMM(TM) for individual patient outcomes. Dominion is continually creating new ways to make physicians' lives easier and patients' lives healthier. Through ongoing research, discovery and development of new approaches to personalized laboratory medicine, Dominion is dedicated to furthering the progress of healthcare today and is raising the standard of care for patients, physicians, and providers.

Dominion Diagnostics is a national medical laboratory fully accredited by the College of American Pathologists (CAP) and certified according to the Clinical Laboratory Improvement Amendments (CLIA). Dominion specializes in advanced, state-of-the-art clinical quantitative urine drug testing and medication monitoring for Pain Management, Addiction Medicine, Primary Care, Workers' Compensation, Mental Health and Well-Being, Behavioral Health, and Hospital Systems.

Media Contact (Dominion Diagnostics):

Julie Lenahan

Director of Marketing

1-401-667-0876

jlenahan@dominiondiagnostics.com


'/>"/>
SOURCE Dominion Diagnostics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dominion Diagnostics Supports Rhode Islands Toys for Tots Initiative at Its 2007 Holiday Celebration
2. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
3. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
4. Hypertension Diagnostics Announces Fiscal Year 2007 Results
5. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
6. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
7. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
8. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
9. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
10. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
11. Quest Diagnostics Reports Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: